Clinical Trial Update: Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating bortezomib, cyclophosphamide, and dexamethasone in patients with AL amyloidosis has completed, with results posted in December 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Decadron (Dexamethasone)
• Velcade (bortezomib)

Snippet

Sponsor: Mayo Clinic | Conditions: Primary Systemic Amyloidosis | Phase 2 | Status: COMPLETED | Results posted: 2012-12-05